文献速递腹部技术与安全CTMR

双层光谱探测器CT动脉期与门静脉期虚拟单能图像对≤30 mm小肝癌的诊断效能:与多期CT及MRI的个体内比较

Diagnostic performance of dual-layer spectral detector CT derived from the arterial and portal venous phases in small HCC (≤ 30 mm): comparison with multiphase CT and MRI.
PubMed 文献 · Abdom Radiol (NY) · 2025-12-12

回顾性纳入136例高危患者共200个≤30 mm未治疗小病灶,比较双层光谱CT动脉期与门静脉期40 keV虚拟单能图像、常规CT图像及多期MRI按LI-RADS v2018 LR-5标准诊断小肝癌的效能;虚拟单能图像敏感度显著高于常规CT,与MRI相当,特异度三者无显著差异。

要点

  • 双层光谱CT动脉期与门静脉期40 keV虚拟单能图像诊断小肝癌的敏感度显著高于常规CT图像。
  • 虚拟单能图像诊断小肝癌的敏感度与多期MRI相当,特异度各模态间无显著差异。
  • 虚拟单能图像未损害特异度,在MRI禁忌或不可及时可能作为HCC诊断的替代选择。

核心结论

  • 双层光谱CT动脉期与门静脉期40 keV虚拟单能图像诊断小肝癌的敏感度与MRI相当但优于常规CT图像,且未损害特异度。

研究设计与样本

  • 回顾性研究,2020年2月至2024年12月纳入136例HCC高危患者共200个经病理或临床随访确认的未治疗小病灶(≤30 mm),均在一个月内完成双层光谱CT与多期MRI。

关键影像表现/征象

  • 双层光谱CT动脉期与门静脉期重建40 keV虚拟单能图像,由两名盲法放射科医师独立评估LI-RADS影像特征并赋类。
  • 常规CT图像、虚拟单能图像及MRI均按LI-RADS v2018标准评估,以LR-5为诊断小肝癌阳性标准。

诊断标准与关键数值

  • 采用LI-RADS v2018 LR-5标准:虚拟单能图像敏感度读者1为76.3%、读者2为78.0%,常规CT图像读者1为64.4%、读者2为66.9%(读者1 P=0.002,读者2 P=0.008)。
  • 虚拟单能图像与MRI敏感度比较:读者1 76.3% vs 74.6%(P=0.64),读者2 78.0% vs 77.1%(P=0.81)。
  • 各模态特异度无显著差异(P=0.26–0.74)。

临床应用与阅片要点

  • 作者认为,当MRI禁忌或不可及时,双层光谱CT 40 keV虚拟单能图像可能作为HCC诊断的可行替代。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic performance of virtual monoenergetic images (VMIs) at 40 keV obtained from dual-layer spectral CT (DLCT) for small HCC (sHCC, ≤ 30 mm) using the LI-RADS version 2018 (i.e., LR-5) by intraindividual comparison with conventional CT images (CIs) and MRI.

MATERIALS AND METHODS: From February 2020 to December 2024, patients who were at high risk of HCC with at least one small noncystic observation (≤ 30 mm) and who underwent both DLCT and multiphase MRI within one month were retrospectively enrolled. VMIs at 40 keV derived from DLCT in the arterial and portal venous phases were reconstructed. Two blinded radiologists independently evaluated the LI-RADS imaging features and assigned categories to CIs, VMIs, and MRI. Sensitivities and specificities for sHCC were compared across modalities using generalized estimating equations.

RESULTS: In total, 136 patients (median age, 56 years [IQR, 48-61 years]; 115 males) with 200 treatment-naïve small observations confirmed by pathology or clinical follow-up were studied. There were 118 HCCs, 23 non-HCC malignancies, and 59 benign observations. When the LR-5 criteria were used, VMIs had significantly higher sensitivity than CIs (reader 1, 76.3% vs. 64.4%, p = 0.002; reader 2, 78.0% vs. 66.9%, p = 0.008) for sHCC and comparable sensitivity to MRI (reader 1, 76.3% vs. 74.6%, p = 0.64; reader 2, 78.0% vs. 77.1%, p = 0.81). The specificities were not significantly different across modalities (p = 0.26-0.74).

CONCLUSIONS: VMIs derived from the arterial and portal venous phases at 40 keV obtained from DLCT had a sensitivity comparable to MRI but superior to CIs for sHCC diagnosis, without impairing specificity. The comparable sensitivity between VMIs and MRI underscores the potential of DLCT as a viable alternative for HCC diagnosis when MRI is contraindicated or unavailable.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Chen J, Shi W, Zhang L, et al. Diagnostic performance of dual-layer spectral detector CT derived from the arterial and portal venous phases in small HCC (≤ 30 mm): comparison with multiphase CT and MRI. Abdom Radiol (NY). 2025. PMID: 41385073. doi:10.1007/s00261-025-05338-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。